Grants and Contributions:
Title:
Development of a novel bi-paratopic therapeutic antibody discovery platform
Agreement Number:
1028865
Agreement Value:
$490,000.00
Agreement Date:
Mar 1, 2025 - Mar 31, 2026
Description:
The project aims to develop a platform for creating and functionally screening very large multispecific libraries for antibody discovery.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1Z3
Reference Number:
172-2024-2025-Q4-1028865
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
725243406
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.
Amendment Date
Nov 20, 2025
Recipient's Legal Name:
Evolved Therapeutics Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: